Thilo Enderle joined HDC GmbH, now Axxam GmbH, as CEO in December 2018. He brings more than 25 years of industry experience spanning from target discovery to preclinical candidate nomination in different settings such as big pharma, biotech and as consultant to VC investors.
From 2016 to 2018 Thilo was Head of Discovery at E-Scape Bio, a biopharmaceutical company in South San Francisco. Prior to this he was Senior Research Director at F. Hoffmann-La Roche in Basel where he led an interdisciplinary team in a global matrix organization. With his teams he was driving more than 100 projects in various disease areas from target assessment to lead optimization.
Thilo is inventor with 12 patent applications for proprietary assay methods and laboratory automation solutions. Thilo received his PhD in Physics from the University of Basel and completed a Postdoc in Biophysics at the Lawrence Berkeley National Laboratory.